Overview

A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The study will be conducted in infants and children with acute otitis media, 6 months to less than 7 years old, in Costa Rica and Israel. The primary objective of this trial will be to describe bacteriologic efficacy in those with initial culture positive specimens with different dosages of faropenem
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Replidyne
Treatments:
beta-Lactams
Criteria
Inclusion Criteria:

- Acute Otis Media

Exclusion Criteria:

- Any antibiotic for more than 24 hours (unless a treatment failure) within 7 days prior
to enrollment